Literature DB >> 8125476

Contiguous deletion and duplication mutations resulting in type 1 hereditary angioneurotic edema.

J J Bissler1, V H Donaldson, A E Davis.   

Abstract

Mutations that cause low antigenic and functional levels of C1 inhibitor protein result in type 1 hereditary angioneurotic edema. This disease is characterized by episodic edema leading to considerable morbidity and sometimes death. We present here two novel mutations in the reactive center coding region. One mutation is a deletion of an imperfect palindrome encompassing nucleotides 1395-1428 and the other is a direct duplication of nucleotides 1414-1433. These mutations do not depend on improper pairing of direct repeats, but may form as a consequence of a peculiar consensus sequence or an alternative secondary structure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8125476     DOI: 10.1007/bf00212020

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

1.  Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment.

Authors:  M Krawczak; D N Cooper
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

2.  Mechanisms of insertional mutagenesis in human genes causing genetic disease.

Authors:  D N Cooper; M Krawczak
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

3.  On the deletion of inverted repeated DNA in Escherichia coli: effects of length, thermal stability, and cruciform formation in vivo.

Authors:  R R Sinden; G X Zheng; R G Brankamp; K N Allen
Journal:  Genetics       Date:  1991-12       Impact factor: 4.562

4.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Demonstration of the production of frameshift and base-substitution mutations by quasipalindromic DNA sequences.

Authors:  J G de Boer; L S Ripley
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

6.  Structural intermediates of deletion mutagenesis: a role for palindromic DNA.

Authors:  B W Glickman; L S Ripley
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  Exon-Alu recombination deletes 5 kilobases from the low density lipoprotein receptor gene, producing a null phenotype in familial hypercholesterolemia.

Authors:  M A Lehrman; D W Russell; J L Goldstein; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  An in vitro approach to identifying specificity determinants of mutagenesis mediated by DNA misalignments.

Authors:  C Papanicolaou; L S Ripley
Journal:  J Mol Biol       Date:  1991-10-05       Impact factor: 5.469

9.  Preferential DNA secondary structure mutagenesis in the lagging strand of replication in E. coli.

Authors:  T Q Trinh; R R Sinden
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

10.  Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains.

Authors:  M A Lehrman; W J Schneider; T C Südhof; M S Brown; J L Goldstein; D W Russell
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

View more
  7 in total

Review 1.  Angioedema associated with C1 inhibitor deficiency.

Authors:  J Laurent; M T Guinnepain
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

2.  Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Authors:  Angelo Agostoni; Emel Aygören-Pürsün; Karen E Binkley; Alvaro Blanch; Konrad Bork; Laurence Bouillet; Christoph Bucher; Anthony J Castaldo; Marco Cicardi; Alvin E Davis; Caterina De Carolis; Christian Drouet; Christiane Duponchel; Henriette Farkas; Kálmán Fáy; Béla Fekete; Bettina Fischer; Luigi Fontana; George Füst; Roberto Giacomelli; Albrecht Gröner; C Erik Hack; George Harmat; John Jakenfelds; Mathias Juers; Lajos Kalmár; Pál N Kaposi; István Karádi; Arianna Kitzinger; Tímea Kollár; Wolfhart Kreuz; Peter Lakatos; Hilary J Longhurst; Margarita Lopez-Trascasa; Inmaculada Martinez-Saguer; Nicole Monnier; István Nagy; Eva Németh; Erik Waage Nielsen; Jan H Nuijens; Caroline O'grady; Emanuela Pappalardo; Vincenzo Penna; Carlo Perricone; Roberto Perricone; Ursula Rauch; Olga Roche; Eva Rusicke; Peter J Späth; George Szendei; Edit Takács; Attila Tordai; Lennart Truedsson; Lilian Varga; Beáta Visy; Kayla Williams; Andrea Zanichelli; Lorenza Zingale
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

3.  Stability of an inverted repeat in a human fibrosarcoma cell.

Authors:  P R Kramer; J R Stringer; R R Sinden
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

4.  A cluster of mutations within a short triplet repeat in the C1 inhibitor gene.

Authors:  J J Bissler; M Cicardi; V H Donaldson; P A Gatenby; F S Rosen; A L Sheffer; A E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

5.  C1 inhibitor gene sequence facilitates frameshift mutations.

Authors:  J J Bissler; Q S Meng; T Emery
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

6.  Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function.

Authors:  E Verpy; E Couture-Tosi; E Eldering; M Lopez-Trascasa; P Späth; T Meo; M Tosi
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

7.  WAO Guideline for the Management of Hereditary Angioedema.

Authors:  Timothy Craig; Emel Aygören-Pürsün; Konrad Bork; Tom Bowen; Henrik Boysen; Henriette Farkas; Anete Grumach; Constance H Katelaris; Richard Lockey; Hilary Longhurst; William Lumry; Markus Magerl; Immaculada Martinez-Saguer; Bruce Ritchie; Alexander Nast; Ruby Pawankar; Bruce Zuraw; Marcus Maurer
Journal:  World Allergy Organ J       Date:  2012-12       Impact factor: 4.084

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.